These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24975810)

  • 1. Antibodies against Haemophilus influenzae type b in The Gambia: investigating the extent of protection across age groups.
    Idoko OT; Roberts E; Cox M; Jafali J; Njie-Jobe J; Mackenzie G; Ota MO; Kampmann B
    Vaccine; 2014 Aug; 32(36):4620-4. PubMed ID: 24975810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.
    Arya BK; Bhattacharya SD; Sutcliffe CG; Saha MK; Bhattacharyya S; Niyogi SK; Moss WJ; Panda S; Das RS; Mallick M; Mandal S
    Vaccine; 2016 Apr; 34(19):2267-74. PubMed ID: 26988256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased disease due to Haemophilus influenzae type b: population-based surveillance in eastern Gambia, 2008-2013.
    Mackenzie GA; Ikumapayi UN; Scott S; Idoko O; Odutola A; Ndiaye M; Sahito SM; Osuorah CD; Manjang A; Jarju S; Bojang A; Roca A; Secka O; Zaman A; Ceesay L; Lowe-Jallow Y; Sambou S; Jasseh M; Antonio M; Greenwood B; Kampmann B; Mulholland K; Corrah T; Howie SR
    Pediatr Infect Dis J; 2015 May; 34(5):e107-12. PubMed ID: 25879650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
    Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
    Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.
    Adegbola RA; Secka O; Lahai G; Lloyd-Evans N; Njie A; Usen S; Oluwalana C; Obaro S; Weber M; Corrah T; Mulholland K; McAdam K; Greenwood B; Milligan PJ
    Lancet; 2005 Jul 9-15; 366(9480):144-50. PubMed ID: 16005337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilus influenzae serotype b seroprevalence in central Lao PDR before and after vaccine introduction.
    Hefele L; Lai J; Vilivong K; Bounkhoun T; Chanthaluanglath V; Chanthongthip A; Balloch A; Black AP; Hübschen JM; Russell FM; Muller CP
    PLoS One; 2022; 17(9):e0274558. PubMed ID: 36107979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection.
    Townsend K; Ladhani SN; Findlow H; Borrow R
    Vaccine; 2014 Sep; 32(43):5650-6. PubMed ID: 25138290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Bowen-Morris J; Griffiths H; Ramsay ME; Deeks JJ; Moxon ER
    JAMA; 2000 Nov; 284(18):2334-40. PubMed ID: 11066183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.
    Klein NP; Abu-Elyazeed R; Cornish M; Leonardi ML; Weiner LB; Silas PE; Grogg SE; Varman M; Frenck RW; Cheuvart B; Baine Y; Miller JM; Leyssen M; Mesaros N; Roy-Ghanta S
    Vaccine; 2017 Jun; 35(28):3564-3574. PubMed ID: 28536030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali.
    Hutter J; Pasetti MF; Sanogo D; Tapia MD; Sow SO; Levine MM
    Am J Trop Med Hyg; 2012 Jun; 86(6):1026-31. PubMed ID: 22665612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.
    Santosham M; Englund JA; McInnes P; Croll J; Thompson CM; Croll L; Glezen WP; Siber GR
    Pediatr Infect Dis J; 2001 Oct; 20(10):931-40. PubMed ID: 11642626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. I. Total antibodies.
    Zarei AE; Redwan EM
    Hum Antibodies; 2018; 26(4):225-235. PubMed ID: 29945350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Children with Haemophilus influenzae type b (Hib) vaccine failure have long-term bactericidal antibodies against virulent Hib strains with multiple capsular loci.
    Townsend-Payne K; Ladhani SN; Findlow H; Slack M; Borrow R
    Vaccine; 2016 Jul; 34(34):3931-4. PubMed ID: 27317452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunogenicity and safety of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in Gambian infants.
    Mulholland EK; Byass P; Campbell H; Fritzell B; Greenwood AM; Todd J; Greenwood BM
    Ann Trop Paediatr; 1994; 14(3):183-8. PubMed ID: 7825990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of conjugate Haemophilus influenzae type B vaccine in The Gambia 14 years after introduction.
    Howie SR; Oluwalana C; Secka O; Scott S; Ideh RC; Ebruke BE; Balloch A; Sambou S; Erskine J; Lowe Y; Corrah T; Adegbola RA
    Clin Infect Dis; 2013 Dec; 57(11):1527-34. PubMed ID: 24046305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales.
    Collins S; Litt D; Almond R; Findlow J; Linley E; Ramsay M; Borrow R; Ladhani S
    J Infect; 2018 Apr; 76(4):335-341. PubMed ID: 29289561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed.
    Breukels MA; Jol-van der Zijde E; van Tol MJ; Rijkers GT
    Clin Infect Dis; 2002 Jan; 34(2):191-7. PubMed ID: 11740707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Haemophilus influenzae Seroprevalence in Serum Samples Collected from 0- to 5-Year-Old Japanese Children in 1980, 1995, 2010, and 2012.
    Arai S; Satoh H; Okuno H; Morino S; Oishi K; Tanaka-Taya K
    Jpn J Infect Dis; 2020 Jan; 73(1):51-54. PubMed ID: 31474695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.